Theoretical carry-over [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2014-01-23 20:57 (4537 d 22:54 ago) – Posting: # 12250
Views: 23,817

Hi rezowan,

❝ Why …


Every regulatory agency is free in their decision to state what in their opinion is “sufficient”. HPFB/TGD wants 10×t½ (<0.1% of theoretical carry-over), ANVISA 7×t½ (<1% CO), where­as EMA, FDA, and many others are happy with just 5×t½ (~3% CO).

❝ … washout period is 10 of half life????

where x = multiple of half lives passed.
┌────┬──────────────┬─────────────┐
│  x │ remain. (%)  │ elimin. (%) │
├────┼──────────────┼─────────────┤
│  0 │ 100          │  0          │
│  1 │  50          │ 50          │
│  2 │  25          │ 75          │
│  3 │  12.5        │ 87.5        │
│  4 │   6.25       │ 93.75       │
│  5 │   3.125      │ 96.875      │
│  6 │   1.5625     │ 98.4375     │
│  7 │   0.78125    │ 99.21875    │
│  8 │   0.390625   │ 99.609375   │
│  9 │   0.1953125  │ 99.8046875  │
│ 10 │   0.09765625 │ 99.90234375 │
└────┴──────────────┴─────────────┘

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
166 visitors (0 registered, 166 guests [including 15 identified bots]).
Forum time: 20:52 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5